Physician profile
Evan Los
NPI 1174842348
$12,516.57
in general payments reported to CMS, 2019-2025
17 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,557 · 2020: $1,625 · 2021: $65.94 · 2022: $3,656 · 2023: $54.46 · 2024: $134 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600 · Travel and Lodging: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.35 |
| Travel and Lodging | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $7,547.07 | 2019-2020 | |
| Medtronic, INC. | $3,935.22 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Dexcom, INC. | $267.87 | 2019-2024 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $243.08 | 2019-2020 | |
| Pfizer INC. | $147.40 | 2020-2025 | |
| Mannkind Corporation | $59.40 | 2019 | |
| Azurity Pharmaceuticals, INC. | $47.03 | 2025 | Triptodur |
| Abbvie INC. | $42.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.92 | 2025 | |
| Sequel Med Tech, LLC | $38.97 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $30.79 | 2024 | |
| Xeris Pharmaceuticals, INC. | $25.65 | 2021 | |
| Jazz Pharmaceuticals INC. | $21.05 | 2020 | |
| Novo Nordisk INC | $19.99 | 2019 | |
| Insulet Corporation | $18.54 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $18.07 | 2019 | |
| Lifescan, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Los listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.